APA:
Copy. (2019). The efficacy and safety of dipeptidyl peptidase-4 inhibitors for type 2 diabetes: a Bayesian network meta-analysis of 58 randomized controlled trials. ACTA DIABETOLOGICA, 56(3), 249-272. SID. https://sid.ir/paper/739166/en
Vancouver:
Copy. The efficacy and safety of dipeptidyl peptidase-4 inhibitors for type 2 diabetes: a Bayesian network meta-analysis of 58 randomized controlled trials. ACTA DIABETOLOGICA[Internet]. 2019;56(3):249-272. Available from: https://sid.ir/paper/739166/en
IEEE:
Copy, “The efficacy and safety of dipeptidyl peptidase-4 inhibitors for type 2 diabetes: a Bayesian network meta-analysis of 58 randomized controlled trials,” ACTA DIABETOLOGICA, vol. 56, no. 3, pp. 249–272, 2019, [Online]. Available: https://sid.ir/paper/739166/en